University of Nottingham CiC#7: accelerating translation of novel, early-stage interdisciplinary, biomedical research

Lead Research Organisation: University of Nottingham
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

The Confidence in Concept (CIC) scheme is a key part of MRC’s translational research strategy and provides annual awards to institutions to flexibly support a portfolio of early stage translational research projects. CIC is designed to accelerate the transition from discovery research to viable translational projects by supporting preliminary studies to establish proof-of-concept so that the approach will then become competitive for more substantial translational funding

Publications

10 25 50

publication icon
Blake H (2020) Perceptions and Experiences of the University of Nottingham Pilot SARS-CoV-2 Asymptomatic Testing Service: A Mixed-Methods Study. in International journal of environmental research and public health

 
Description A biopesticidal lease of life for crop protection : additive manufacturing for tailored timing of biopesticide release by natural triggers
Amount £129,319 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 06/2022 
End 07/2023
 
Description Coordinating COVID-19 Asymptomatic Testing Programmes In University Settings: Providing Insight On Acquired Immunity Across The Student Population
Amount £7,200,000 (GBP)
Organisation United Kingdom Research and Innovation 
Sector Public
Country United Kingdom
Start 09/2020 
End 03/2021
 
Description DEfining MechanIsms Shared across mulTI-organ FIbrotic disease to prevent the development of long term multi-morbidity
Amount £1,595,600 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 11/2021 
End 10/2025
 
Description Development of novel broad-spectrum antiviral compounds for use in animals and humans
Amount £764,392 (GBP)
Organisation Biotechnology and Biological Sciences Research Council (BBSRC) 
Sector Public
Country United Kingdom
Start 01/2022 
End 01/2024
 
Description Dialling Up Performance For On Demand Manufacturing
Amount £5,865,356 (GBP)
Organisation Engineering and Physical Sciences Research Council (EPSRC) 
Sector Public
Country United Kingdom
Start 09/2022 
End 09/2027
 
Description Gut-Imaging For Function And Transit In CF - GIFT-CFX-Junior Bridging Grant
Amount £6,500 (GBP)
Organisation Nottingham Hospitals Charity 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2022 
End 01/2023
 
Description MICRA grant to Prof. Ilyas
Amount £15,000 (GBP)
Organisation United Kingdom Research and Innovation 
Sector Public
Country United Kingdom
Start 04/2020 
End 06/2021
 
Description MICRA grant to Prof. Notingher
Amount £7,400 (GBP)
Organisation United Kingdom Research and Innovation 
Sector Public
Country United Kingdom
Start 04/2020 
End 06/2021
 
Description Preclinical Safety And Efficacy Of Cathelicidin-derived Peptide And Vancomycin Combination For Pseudomonas Keratitis
Amount £76,000 (GBP)
Organisation Rosetrees Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 07/2020 
End 01/2022
 
Description Quantitative Reporting in Crohn's Disease: Maximising available MRI data to better direct patient treatment, speed up treatment decisions and improve healthcare outcomes
Amount £1,574,000 (GBP)
Organisation Innovate UK 
Sector Public
Country United Kingdom
Start 03/2020 
End 03/2023
 
Description Research Collaborative - DEMISTIFI Multi Morbidity: DEfining MechanIsms Shared across mulTI-organ FIbrotic disease to prevent the development of long term multi-morbidity
Amount £3,335,901 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 06/2021 
End 06/2025
 
Description TOPICAL
Amount £99,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2021 
End 01/2022
 
Description Towards Precision Medicine: a MagnEtic Resonance Imaging-based measure of fibrosis in enTeric Crohn's disease. The MERIT study
Amount £10,000 (GBP)
Organisation Bowel Cancer UK 
Sector Charity/Non Profit
Country United Kingdom
Start 01/2021 
End 12/2022
 
Description Vertex Pharmaceuticals grant to coI Andrew Prayle
Amount £225,000 (GBP)
Organisation Vertex Pharmaceuticals 
Sector Private
Country United States
Start  
 
Description Preparing for first in man trials of 3D printed solid dosage forms 
Organisation Added Scientific Ltd
Country United Kingdom 
Sector Private 
PI Contribution Staff, research expertise and know-how
Collaborator Contribution Facilities and expertise to perform work in GMP environment
Impact No outcomes as of yet, project still in progress. Project is multi-disciplinary, bringing together engineering and pharmacy teams
Start Year 2019
 
Description Preparing for first in man trials of 3D printed solid dosage forms 
Organisation AstraZeneca
Country United Kingdom 
Sector Private 
PI Contribution Staff, research expertise and know-how
Collaborator Contribution Facilities and expertise to perform work in GMP environment
Impact No outcomes as of yet, project still in progress. Project is multi-disciplinary, bringing together engineering and pharmacy teams
Start Year 2019
 
Description Preparing for first in man trials of 3D printed solid dosage forms 
Organisation Quotient Clinical Ltd
Country United Kingdom 
Sector Private 
PI Contribution Staff, research expertise and know-how
Collaborator Contribution Facilities and expertise to perform work in GMP environment
Impact No outcomes as of yet, project still in progress. Project is multi-disciplinary, bringing together engineering and pharmacy teams
Start Year 2019
 
Description Protein quality reference score for assessing digestibility 
Organisation Arla Foods
Country United Kingdom 
Sector Private 
PI Contribution Provision of research labs, staff, patients and expertise from academics
Collaborator Contribution Provision of labelled proteins and expertise
Impact None yet
Start Year 2019
 
Title ANTIVIRAL COMPOUNDS AND METHODS 
Description The invention provides an agent for the treatment or prevention of viral infection in a subject. The agent is preferably a compound of Formula (I) or (la) wherein R1-R4, A and B are as defined herein. Also provided are pharmaceutical compositions and combinations comprising such agents. 
IP Reference WO2021069891 
Protection Patent application published
Year Protection Granted 2021
Licensed No
Impact None as yet
 
Title SOCE FACILITATORS FOR USE IN TREATING OR PREVENTING VIRAL INFECTIONS 
Description Published online 
IP Reference GB2020/052479 
Protection Patent application published
Year Protection Granted
Licensed No
Impact Impact exploration ongoing